Center-Authored Papers

Filters: Author is Chen, George L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2011
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Adrenal Cortex Hormones
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Adult
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Aged
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Antibodies, Monoclonal
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Bioinformatics Core Facility
Yu J, Storer BE, Kushekhar K, Abu Zaid M, Zhang Q, Gafken PR, Ogata Y, Martin PJ, Flowers ME, Hansen JA et al..  2016.  Biomarker Panel for Chronic Graft-Versus-Host Disease.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(22):2583-2590. Abstract
Center-Authored Paper
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Clinical Research Division
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Disease-Free Survival
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Drug Resistance
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Female
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Follow-Up Studies
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Genomics Core Facility
Yu J, Storer BE, Kushekhar K, Abu Zaid M, Zhang Q, Gafken PR, Ogata Y, Martin PJ, Flowers ME, Hansen JA et al..  2016.  Biomarker Panel for Chronic Graft-Versus-Host Disease.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(22):2583-2590. Abstract
Graft vs Host Disease
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Humans
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Male
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Middle Aged
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Piperazines
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Proteomics Core Facility
Yu J, Storer BE, Kushekhar K, Abu Zaid M, Zhang Q, Gafken PR, Ogata Y, Martin PJ, Flowers ME, Hansen JA et al..  2016.  Biomarker Panel for Chronic Graft-Versus-Host Disease.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(22):2583-2590. Abstract
Pyrimidines
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
Receptor, Platelet-Derived Growth Factor alpha
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract
September 2011
Chen GL, Arai S, Flowers MED, Otani JM, Qiu J, Cheng EC, McMillan A, Johnston LJ, Shizuru JA, Miklos DB.  2011.  A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.. Blood. 118(15):4070-4078. Abstract